Multilocular cystic renal cell tumors with Xp11 translocation-associated renal cell carcinoma features; report of 2 cases and review of literature

[1]  Dibson D. Gondim,et al.  Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey , 2021, Journal of Clinical Pathology.

[2]  H. Zeng,et al.  Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis , 2020, Journal of Clinical Pathology.

[3]  P. Argani,et al.  MiT family translocation renal cell carcinomas: A 15th anniversary update. , 2020, Histology and histopathology.

[4]  Yongjie Ma,et al.  Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis , 2019, Modern Pathology.

[5]  X. Teng,et al.  RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations , 2018, Modern Pathology.

[6]  Dongmei Li,et al.  Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion , 2017, The Journal of international medical research.

[7]  Erika J. Thompson,et al.  Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas , 2017, Histopathology.

[8]  C. Antonescu,et al.  TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers , 2016, The American journal of surgical pathology.

[9]  A. Naranjo,et al.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2 , 2015, Cancer.

[10]  M. Ladanyi,et al.  Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage , 2014, Modern Pathology.

[11]  M. Ladanyi,et al.  Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service , 2013, The American journal of surgical pathology.

[12]  D. Grignon,et al.  TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone: Expanding the Morphologic Spectrum , 2013, The American journal of surgical pathology.

[13]  T. Klatte,et al.  Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis. , 2012, American journal of clinical pathology.

[14]  P. Schirmacher,et al.  Molecular heterogeneity of TFE3 activation in renal cell carcinomas , 2012, Modern Pathology.

[15]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical Profile Emphasizing Novel RCC Markers , 2010, The American journal of surgical pathology.

[16]  P. Argani,et al.  Xp11 Translocation Renal Cell Carcinoma , 2010, Pathology.

[17]  L. Cheng,et al.  Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation‐associated and unusual clear cell subtypes , 2008, Histopathology.

[18]  Karl J. Dykema,et al.  Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases With a Review of the Literature , 2008, The American journal of surgical pathology.

[19]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[20]  P. Argani,et al.  Xp11 Translocation Carcinoma of the Kidney Presenting With Multilocular Cystic Renal Cell Carcinoma-Like Features , 2007, International journal of surgical pathology.

[21]  M. Ladanyi,et al.  Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Ladanyi,et al.  Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.

[23]  M. Ladanyi,et al.  PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21) , 2002, The American journal of surgical pathology.

[24]  P. Argani,et al.  A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. , 2001, The American journal of pathology.